+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Non Hodgkin Lymphoma Drug"

B-Cell Non-Hodgkin Lymphoma - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

B-Cell Non-Hodgkin Lymphoma - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Non-Hodgkin's Lymphoma (NHL) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Non-Hodgkin's Lymphoma (NHL) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
CAR T-Cell Therapy for Non-Hodgkin's lymphoma (NHL) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

CAR T-Cell Therapy for Non-Hodgkin's lymphoma (NHL) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Non-Hodgkin's Lymphoma (NHL) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Non-Hodgkin's Lymphoma (NHL) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Global Non-Hodgkin Lymphoma Therapeutics Market 2023-2027 - Product Thumbnail Image

Global Non-Hodgkin Lymphoma Therapeutics Market 2023-2027

  • Report
  • February 2023
  • 174 Pages
  • Global
From
US Non-Hodgkin Lymphoma Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Non-Hodgkin Lymphoma Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
Global Non-Hodgkin Lymphoma Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Non-Hodgkin Lymphoma Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Global Non-Hodgkin Lymphoma Epidemiology and Patient Flow - 2021 - Product Thumbnail Image

Global Non-Hodgkin Lymphoma Epidemiology and Patient Flow - 2021

  • Report
  • February 2021
  • Global
From
Europe Non-Hodgkin Lymphoma Market and Competitive Landscape - 2021 - Product Thumbnail Image

Europe Non-Hodgkin Lymphoma Market and Competitive Landscape - 2021

  • Report
  • August 2021
  • Europe
From
Global Non-Hodgkin Lymphoma Market and Competitive Landscape - 2021 - Product Thumbnail Image

Global Non-Hodgkin Lymphoma Market and Competitive Landscape - 2021

  • Report
  • August 2021
  • Global
From
B-Cell Non-Hodgkin Lymphoma (NHL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

B-Cell Non-Hodgkin Lymphoma (NHL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • January 2023
  • 123 Pages
  • Global
From
B-Cell Non-Hodgkins Lymphoma Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

B-Cell Non-Hodgkins Lymphoma Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • December 2022
  • 36 Pages
  • Global
From
B-Cell Non-Hodgkin's Lymphoma: Epidemiology Forecast to 2027 - Product Thumbnail Image

B-Cell Non-Hodgkin's Lymphoma: Epidemiology Forecast to 2027

  • Report
  • June 2019
  • 44 Pages
  • Global
From
Non-Hodgkin Lymphoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Non-Hodgkin Lymphoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 3999 Pages
  • Global
From
Africa Non-hodgkin Lymphoma Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Africa Non-hodgkin Lymphoma Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • January 2022
  • 80 Pages
  • Africa
From
India Non-hodgkin Lymphoma Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

India Non-hodgkin Lymphoma Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • January 2022
  • 40 Pages
  • India
From
Saudi Arabia Non-hodgkin Lymphoma Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Saudi Arabia Non-hodgkin Lymphoma Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • January 2022
  • 40 Pages
  • Saudi Arabia
From
Non-Hodgkin Lymphoma Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Non-Hodgkin Lymphoma Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • June 2023
  • 93 Pages
  • Global
From
Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 1814 Pages
  • Global
From
B-Cell Non-Hodgkin Lymphoma (Oncology) - Drugs in Development, 2021 - Product Thumbnail Image

B-Cell Non-Hodgkin Lymphoma (Oncology) - Drugs in Development, 2021

  • Report
  • April 2021
  • 220 Pages
  • Global
From
Loading Indicator

The Non Hodgkin Lymphoma Drug market is a subset of the larger Lymphoma Drugs market. Non Hodgkin Lymphoma (NHL) is a type of cancer that affects the lymphatic system, and is the seventh most common cancer in the United States. Treatment for NHL typically involves chemotherapy, radiation, and targeted therapies. The Non Hodgkin Lymphoma Drug market is composed of a variety of drugs used to treat NHL, including monoclonal antibodies, small molecule drugs, and immunomodulators. These drugs are used to target specific proteins and pathways involved in the development and progression of NHL. Some of the major companies in the Non Hodgkin Lymphoma Drug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Celgene, Eli Lilly, Genentech, Merck, Novartis, Pfizer, and Roche. Show Less Read more